The single-arm, multi-institutional clinical trial - conducted by the Blood and Marrow Transplant Clinical Trials Network in collaboration with the AIDS Malignancy Clinical Trials Consortium - followed the progress of 40 patients with treatable HIV-1 infection 15 years of age and older who underwent autologous blood stem cell transplantation for lymphoma. The trial found an estimated one-year progression-free survival rate of 82.3 percent in these patients, all of whom had failed prior therapy.
http://ift.tt/1q7QP0v
http://ift.tt/1q7QP0v
No comments:
Post a Comment